1Herman J R,Adler H L,Aguilar-Cordova E,et al.In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial [J].Hum Gen Ther,1999,10(7): 1239.
2Haberkorn U,Khazaie K,Morr I,et al.Ganciclovir uptake in human mammary carcinoma cells expressing herpes simplex virus thymidine kinase [J].Nucl Med Biol,1998,25(4): 367.
3Rosolen A,Frascella E,Di-Frascesso C,et al.In vitro and in vivo antitumor effects of retrovirus-mediated perpes simplex thymidine kinase gene-transfer in human medulloblastoma[J].Gene Ther,1998,5(1): 113.
4Craperi D,Vicat J M,Nissou M F,et al.Increased bax expression is associated with cell death induced by ganciclovir in a herpes thymidine kinase gene-expressing glioma cell line[J].Hum Gen Ther,1999,10(4): 679.
5Fick J,Barker F G,Dazing P,et al.The extent of heterocellular communication mediated by gap junctions is predictive of bystander tumor cytotoxicity in vitro[J].Proc Natl Acad Sci USA,1995,92(24): 11071.
6Kaneko Y,Tsukamoto A.Gene therapy of hepatoma: bystander effects and non-apoptotic cell death induced by thymidine kinase and ganciclovir[J].Cancer Lett,1995,96(1):105.
7Colombo B M,Benedetti S,Ottolenghi S,et al.The "bystander effect": association of U-87 cell death with ganciclovir-mediated apoptosis of nearby cells and lack of effect in athymic mice[J].Hum Gen Ther,1995,6(6): 763.
8Li P X,Ngo D,Brade A M,et al.Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer[J].Cancer Gene Ther,1999,6(2): 179.
9Andrade Rozental AF,Rozental R,Hopperstad MG,et al.Gap junctions: the "kiss of death" and "kiss of life"[J].Brain Res Brain Res Rev,2000,32(1): 308
